Allium Financial Advisors’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.43M Sell
1,195
-1
-0.1% -$1.02K 0.94% 23
2026
Q1
$1.1M Buy
1,196
+9
+0.8% +$9.12K 0.88% 21
2025
Q4
$1.28M Hold
1,187
1.01% 20
2025
Q3
$906K Sell
1,187
-174
-13% -$129K 0.75% 26
2025
Q2
$1.06M Buy
1,361
+1
+0.1% +$777 0.92% 21
2025
Q1
$1.12M Buy
+1,360
New +$1.13M 1.02% 18

Other funds holding LLY

Allium Financial Advisors's LLY Position: Q2 2026 in Review

Allium Financial Advisors reduced its Eli Lilly (LLY) stake by 0.08% in Q2 2026, selling an estimated $1.02K and leaving 1,195 shares worth $1.43M. The position accounts for 0.94% of the portfolio, ranked #23.

Allium Financial Advisors first reported a position in LLY in Q1 2025 and has held it in 6 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Allium Financial Advisors held 1,195 shares of Eli Lilly worth $1.43M as of Q2 2026.
  • Allium Financial Advisors sold 1 Eli Lilly share in Q2 2026, an estimated $1.02K.
  • Eli Lilly made up 0.94% of Allium Financial Advisors's portfolio in Q2 2026, its #23 holding.
  • Allium Financial Advisors first reported a position in Eli Lilly in Q1 2025 and has held it in 6 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Allium Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.